Report on Future Trends in
Alzheimer's Disease

A reinsurance company was reviewing its policies for chronic illnesses and was unsure about the outlook for Alzheimer's Disease, in terms of both incidence and therapeutic options. They needed rapid yet in depth insights into the outlook for new diagnostics and therapies. Within two weeks our client was in deep discussion with five of the world's leading clinicians and research scientists in the field. Two lively and intense sessions were held, each moderated by a prominent clinician who led the discussions through all the nuances of the issues. We captured the discussions in a high quality recording, prepared a transcript and delivered these to the client along with our written summary of the findings.